Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hayakawa

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
Leukemia|March 23, 2016
Development and analysis of patient-derived xenograft mouse models in intravascular large B-cell lymphomaK Shimada, S Shimada, K Sugimoto, et al.
Blood Cancer Journal|October 18, 2014
Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study GroupF Hayakawa, T Sakura, T Yujiri, et al.
Leukemia|September 16, 2017
High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: a phase III study by JALSGT Sakura, F Hayakawa, I Sugiura, et al.
The Japanese Journal of Antibiotics|July 1, 1997
[Pharmacokinetic and clinical studies with cefluprenam in the pediatric field. Pediatric Study Group of Gefluprenam]R Fujii, T Abe, T Tajima, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
Leukemia|March 23, 2016
Development and analysis of patient-derived xenograft mouse models in intravascular large B-cell lymphomaK Shimada, S Shimada, K Sugimoto, et al.
Blood Cancer Journal|October 18, 2014
Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study GroupF Hayakawa, T Sakura, T Yujiri, et al.
Leukemia|September 16, 2017
High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: a phase III study by JALSGT Sakura, F Hayakawa, I Sugiura, et al.
The Japanese Journal of Antibiotics|July 1, 1997
[Pharmacokinetic and clinical studies with cefluprenam in the pediatric field. Pediatric Study Group of Gefluprenam]R Fujii, T Abe, T Tajima, et al.
Pageof 11